ClearPoint congratulates partner PTC Therapeutics on completion of its BLA
PremiumThe FlyClearPoint congratulates partner PTC Therapeutics on completion of its BLA
4M ago
ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiency
PremiumPress Releases
ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiency
4M ago
ClearPoint Neuro price target raised to $9 from $8 at Stifel
PremiumThe Fly
ClearPoint Neuro price target raised to $9 from $8 at Stifel
5M ago
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results  March 12, 2024
PremiumPress ReleasesClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024
5M ago
ClearPoint Neuro 2.31M share Spot Secondary priced at $6.50
PremiumThe Fly
ClearPoint Neuro 2.31M share Spot Secondary priced at $6.50
5M ago
ClearPoint Neuro Launches Proposed Public Offering of Common Stock
PremiumPress Releases
ClearPoint Neuro Launches Proposed Public Offering of Common Stock
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100